Universal Screening for Blunt Cerebrovascular Injury
NCT07919847, Not applicable, Not yet recruiting, Inova Health Care Services
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Universal Screening for Blunt Cerebrovascular Injury | ClinicalTrials.gov |
| NCT number | NCT07919847 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 5,000 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Inova Health Care Services | ClinicalTrials.gov |
| Conditions | Cerebrovascular Trauma | ClinicalTrials.gov |
| Interventions | Selective Screening, Universal Screening | ClinicalTrials.gov |
| First posted | 2026-11-05 | ClinicalTrials.gov |
| Last updated | 2026-11-05 | ClinicalTrials.gov |
Registered outcomes 6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Number of Participants with BCVI-related Ischemic Stroke | In-hospital, from admission to discharge or in-hospital death; aggregated over the 12-month data-collection period by screening condition | BCVI-related ischemic stroke is defined as any ischemic stroke occurring during the hospital stay in a vascular territory suggestive of cervical arterial injury, or any ischemic stroke occurring during the hospital stay in a patient with confirmed BCVI (or before discharge or patient death). Strokes present on admission imaging will be recorded but analyzed separately and not classified as BCVI-related. | ClinicalTrials.gov |
| Secondary | Incidence of BCVI-Related Stroke per 1000 Major Blunt Trauma Admissions | From hospital admission until hospital discharge or in-hospital death, whichever occurs first (up to 14 days) | Incidence of BCVI-related stroke, measured at the population level as events per 1,000 major blunt trauma admissions and compared between screening conditions. BCVI-related stroke is any in-hospital ischemic stroke in a vascular territory suggestive of cervical arterial injury or in a patient with confirmed BCVI; hemorrhagic strokes and strokes on admission imaging are excluded. | ClinicalTrials.gov |
| Secondary | Incidence of Stroke-Related Mortality per 1,000 Major Blunt Trauma Admissions | From hospital admission until hospital discharge or in-hospital death, whichever occurs first (up to 14 days) | Incidence of stroke-related death, measured at the population level as events per 1,000 major blunt trauma admissions and compared between screening conditions. Stroke-related death is any in-hospital death deemed by the treatment team to result primarily from a BCVI-related stroke. | ClinicalTrials.gov |
| Other | Antithrombotic-related bleeding | During the hospitalization for the traumatic event, up to 14 days | Incidence of antithrombotic-related bleeding events | ClinicalTrials.gov |
| Other | BCVI detection rate | In-hospital, from admission to discharge or in-hospital death; aggregated over the 12-month data-collection period by screening condition | Rate of BCVI diagnoses per 1000 patients screened | ClinicalTrials.gov |
| Other | CTA utilization | In-hospital, from admission to discharge or in-hospital death; aggregated over the 12-month data-collection period by screening condition | CTAs performed per 1000 major blunt trauma admissions per institution | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 22
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|---|---|
| 2388306 | BACKGROUND | PubMed |
| 10568710 | BACKGROUND | PubMed |
| 10670864 | BACKGROUND | PubMed |
| 22327974 | BACKGROUND | PubMed |
| 23185138 | BACKGROUND | PubMed |
| 24458034 | BACKGROUND | PubMed |
| 24553535 | BACKGROUND | PubMed |
| 27027559 | BACKGROUND | PubMed |
| 27751528 | BACKGROUND | PubMed |
| 29847537 | BACKGROUND | PubMed |
| 31818147 | BACKGROUND | PubMed |
| 32176167 | BACKGROUND | PubMed |
| 32370960 | BACKGROUND | PubMed |
| 32520898 | BACKGROUND | PubMed |
| 33502144 | BACKGROUND | PubMed |
| 34016922 | BACKGROUND | PubMed |
| 36101794 | BACKGROUND | PubMed |
| 36440860 | BACKGROUND | PubMed |
| 36841698 | BACKGROUND | PubMed |
| 38253324 | BACKGROUND | PubMed |
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)